Neoplasm
Definition: An abnormal tissue growth resulted from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)
Synonyms (terms occurring on more labels are shown first): tumors, tumor, neoplasm, neoplasms, neoplasia, tumour, tumours, neoplastic disease, neoplasm nos
More information: PubMed search and possibly Wikipedia or Medpedia
Proteins predicted to cause Neoplasm:
CYP3A4
(1 prediction in total)
Show drugs for which this side effect directly occurs
Drugs with this side effect as MedDRA Preferred Term
- Corticotropin
- Pentostatin
- Tacrine Hydrochloride Capsules
- Tolcapone
- alkeran
- alprostadil
- altretamine
- amsacrine
- anastrozole
- Neoplasm: postmarketing, 2.96% - 3.52%
- azacitidine
- azathioprine
- bendamustine
- bicalutamide
- bortezomib
- Neoplasm: postmarketing
- Solid tumour: postmarketing
- bupropion
- buserelin (buserelin acetate)
- busulfan
- caspofungin (caspofungin acetate)
- celecoxib
- cevimeline hydrochloride
- citalopram
- Neoplasm: rare, infrequent
- cladribine
- clarithromycin
- clofarabine
- cyclosporine
- cytarabine
- danazol
- daunorubicin
- docetaxel
- Neoplasm: postmarketing
- Solid tumour
- doxazosin
- doxepin
- doxorubicin hydrochloride
- dutasteride
- estrogens, conjugated
- eszopiclone
- exemestane
- felbamate
- fentanyl
- finasteride
- fludarabine
- Neoplasm: postmarketing
- Solid tumour: postmarketing
- flutamide
- fluvoxamine maleate
- formoterol fumarate
- forteo
- fosaprepitant dimeglumine
- foscarnet sodium
- gabapentin
- gadobenic acid
- glatiramer acetate
- Neoplasm: postmarketing, infrequent
- gliclazide
- hydromorphone
- ibuprofen
- insulin recombinant human
- invirase
- irinotecan
- lamotrigine
- lansoprazole
- lenalidomide
- letrozole
- levofloxacin
- levonorgestrel
- lisinopril
- lubiprostone
- maraviroc
- medroxyprogesterone acetate
- methylnaltrexone bromide
- methylphenidate hydrochloride
- metronidazole
- mitoxantrone
- moxifloxacin hydrochloride
- mustargen
- mycophenolic acid
- nandrolone
- naproxen
- naratriptan
- nexavar
- niacin
- nitisinone
- norethindrone
- omeprazole
- oxycodone
- oxymetholone
- paclitaxel
- pantoprazole
- paricalcitol
- paroxetine
- Neoplasm: rare, postmarketing
- pergolide mesylate
- Neoplasm: rare, infrequent
- pimecrolimus
- pioglitazone (pioglitazone hydrochloride)
- plerixafor
- posaconazole
- pramipexole dihydrochloride monohydrate
- prednisone
- pregabalin
- prezista
- progesterone
- rabeprazole sodium
- relpax
- rifapentine
- riluzole
- Neoplasm: rare, infrequent
- risperidone
- rivastigmine
- rofecoxib
- ropinirole
- Neoplasm: rare, infrequent
- selegiline
- Neoplasm: rare, infrequent
- sirolimus
- sitaxsentan sodium
- sprycel
- sumatriptan (sumatriptan succinate)
- sutent
- tacrolimus
- Neoplasm: postmarketing, 1% - 2%
- tarceva
- teniposide
- thalidomide
- tiagabine hydrochloride
- tipranavir
- topiramate
- topotecan
- tramadol
- ursodiol
- valcyte
- valdecoxib
- valproic acid
- vinorelbine
- warfarin
- zelnorm
- zolmitriptan
- zolpidem
|
Drugs with this indication
|